Cancer patients and COVID-19 (search done on 5 April 2020)

Added June 25, 2020

Citation: Moujaess E, Kourie HR, Ghosn M. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Critical Reviews in Oncology/Hematology. 2020 Jun;150:102972.

What is this? Some patients with cancer will contract COVID-19.

In this rapid review, the authors searched for studies that investigated the clinical characteristics of adult cancer patients who contracted COVID-19. They restricted their searches to articles published in English, French or Chinese since December 2019 and did the search on 5 April 2020. They included 68 opinion publications and 20 observational studies.

What was found: At the time of the review, the included studies showed that COVID-19 can present differently in patients with cancer compared to the general population, which might make COVID-19 diagnosis more challenging in patients with cancer.

At the time of the review, the included studies showed that cancer treatments and cancer research had been adversely affected by the COVID-19 pandemic.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.